SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
04-Mar-22 5:39 PM View: | Quince Therapeutics, Inc. (QNCX) | 03-Mar-22 | Grant | 140,000 | -- | -- | 100% 0 to 140.0K | |
07-Jul-21 8:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 07-Jul-21 | Option Exercise | 17,400 | $2.23 | $38,802.00 | 100% 0 to 17.4K | |
07-Jul-21 8:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 07-Jul-21 | Market Sale (Planned) | 17,400 | $55.20 | $960,549.00 | (100%) 17.4K to 0 | |
07-Jul-21 8:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 06-Jul-21 | Option Exercise | 12,600 | $2.23 | $28,098.00 | 45% 28.26K to 40.86K | |
07-Jul-21 8:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 06-Jul-21 | Market Option Sale (Planned) | 30,000 | $53.54 | $1,606,150.00 | (73%) 40.86K to 10.86K | |
07-Jul-21 8:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 06-Jul-21 | Market Sale (Planned) | 10,861 | $53.54 | $581,478.00 | (100%) 10.86K to 0 | |
29-May-20 4:48 PM View: | Quince Therapeutics, Inc. (QNCX) | 27-May-20 | Option Exercise | 5,515 | $6.91 | $38,108.60 | 24% 22.75K to 28.26K | |
06-Apr-20 5:39 PM View: | Quince Therapeutics, Inc. (QNCX) | 02-Apr-20 | Option Exercise | 5,515 | $6.91 | $38,108.60 | 32% 17.23K to 22.75K | |
10-Feb-20 6:15 PM View: | Quince Therapeutics, Inc. (QNCX) | 07-Feb-20 | Option Exercise | 17,231 | $6.91 | $119,066.00 | 100% 0 to 17.23K |